Fuyuan Pharmaceutical (601089.SH): ripropyl dicaine cream obtained drug registration certificate

Zhitongcaijing · 07/04 07:49

Zhitong Finance App News, Fuyuan Pharmaceutical (601089.SH) issued an announcement. Recently, Fuyuan Pharmaceutical Co., Ltd. (hereinafter referred to as “Fuyuan Pharmaceutical”), a wholly-owned subsidiary of the company, received ripropyl dicaine cream (specification: 5g: lidocaine 125 mg and propylaminocaine 125 mg, hereinafter referred to as “this drug”) “Drug Registration Certificate” (certificate number: 2025S02053) issued by the China Drug Administration (hereinafter referred to as the “State Drug Administration”).